Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety

Jie Mao^#¹, Shujun Liu^#¹, Min Ai^#², Zhuo Wang³, Duowei Wang¹, Xianjing Li¹, Kaiyong Hu¹, Xinghua Gao^{4

5}, Yong Yang^{6

7}

Affiliations

¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China.
² The Second Hospital of Nanjing, Nanjing, 320100, China.
³ School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
⁴ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China. 1620154324@cpu.edu.cn.
⁵ Institute of Pharmaceutical Science, China Pharmaceutical University, No 639, Longmian Rd., Nanjing, 211198, China. 1620154324@cpu.edu.cn.
⁶ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China. valianty@hotmail.com.
⁷ Institute of Pharmaceutical Science, China Pharmaceutical University, No 639, Longmian Rd., Nanjing, 211198, China. valianty@hotmail.com.

^# Contributed equally.

Published Erratum

Jie Mao et al. J Hematol Oncol. 2022.

. 2022 Sep 9;15(1):130.

doi: 10.1186/s13045-022-01277-5.

Jie Mao^#¹, Shujun Liu^#¹, Min Ai^#², Zhuo Wang³, Duowei Wang¹, Xianjing Li¹, Kaiyong Hu¹, Xinghua Gao^{4

5}, Yong Yang^{6

7}

¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China.
² The Second Hospital of Nanjing, Nanjing, 320100, China.
³ School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
⁴ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China. 1620154324@cpu.edu.cn.
⁵ Institute of Pharmaceutical Science, China Pharmaceutical University, No 639, Longmian Rd., Nanjing, 211198, China. 1620154324@cpu.edu.cn.
⁶ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China. valianty@hotmail.com.
⁷ Institute of Pharmaceutical Science, China Pharmaceutical University, No 639, Longmian Rd., Nanjing, 211198, China. valianty@hotmail.com.

^# Contributed equally.

No abstract available

Erratum for

A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety.
Mao J, Liu S, Ai M, Wang Z, Wang D, Li X, Hu K, Gao X, Yang Y. Mao J, et al. J Hematol Oncol. 2017 Mar 20;10(1):71. doi: 10.1186/s13045-017-0442-y. J Hematol Oncol. 2017. PMID: 28320480 Free PMC article.

1. Mao J, et al. A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety. J Hematol Oncol. 2017;10:71. doi: 10.1186/s13045-017-0442-y. - DOI - PMC - PubMed